Truist Securities Maintains Hold on Pediatrix Medical Group, Maintains $10 Price Target
Portfolio Pulse from Benzinga Newsdesk
Truist Securities analyst David Macdonald maintains a Hold rating on Pediatrix Medical Group (NYSE:MD) with a $10 price target.
May 15, 2024 | 6:23 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Truist Securities has reiterated its Hold rating on Pediatrix Medical Group with a $10 price target, indicating a neutral stance on the stock.
The Hold rating and maintained price target suggest that the analyst does not foresee significant short-term movement in the stock price. This neutral stance indicates that investors should not expect major changes in the stock's performance based on this rating alone.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100